Uses of bremelanotide in therapy for female sexual dysfunction

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9352013
SERIAL NO

14313258

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Use of a subcutaneously administered dose of between about 1.0 mg and 1.75 mg of bremelanotide or a pharmaceutically acceptable salt of bremelanotide for the treatment of female sexual dysfunction in women while reducing or minimizing undesirable side effects.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
COSETTE PHARMACEUTICALS INC200 CROSSING BLVD BRIDGEWATER NJ 08807

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Edelson, Jeffrey D Berwyn, US 11 17
Jordan, Robert Hamilton, US 67 1258
Spana, Carl West Harrison, US 13 29

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 30, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00